PURPOSE: To determine whether there is a significant association between human immunodeficiency virus (HIV)-related retinal microangiopathy and systemic cytomegalovirus (CMV) disease in HIV-infected patients. METHODS: Participants in this single-center, cross-sectional, retrospective study were 383 HIV-infected patients assessed for ocular manifestations before the beginning of antiretroviral therapy. The presence of HIV-related retinal microangiopathy, the presence of systemic CMV disease, laboratory data, and demographic information were determined by referring to medical records. The significance of any association between HIV-related retinal microangiopathy and systemic CMV disease was determined by use of the Chi-squared test and by multivariate analysis. RESULTS: HIV-related retinal microangiopathy was present in 85 patients, and was significantly associated with systemic CMV disease both by use of the Chi-squared test (P = 0.006) and by multivariate analysis (P = 0.045, odds ratio 2.03, 95 % confidence interval 1.02-4.06 adjusted for CD4+ cell count and plasma HIV-RNA level). CONCLUSIONS: These findings indicate that microangiopathy may be involved in the development of CMV disease in HIV-infected patients. Thus, detection of the presence of HIV-related retinal microangiopathy is important in the management of HIV-infected patients.
PURPOSE: To determine whether there is a significant association between human immunodeficiency virus (HIV)-related retinal microangiopathy and systemic cytomegalovirus (CMV) disease in HIV-infectedpatients. METHODS:Participants in this single-center, cross-sectional, retrospective study were 383 HIV-infectedpatients assessed for ocular manifestations before the beginning of antiretroviral therapy. The presence of HIV-related retinal microangiopathy, the presence of systemic CMV disease, laboratory data, and demographic information were determined by referring to medical records. The significance of any association between HIV-related retinal microangiopathy and systemic CMV disease was determined by use of the Chi-squared test and by multivariate analysis. RESULTS:HIV-related retinal microangiopathy was present in 85 patients, and was significantly associated with systemic CMV disease both by use of the Chi-squared test (P = 0.006) and by multivariate analysis (P = 0.045, odds ratio 2.03, 95 % confidence interval 1.02-4.06 adjusted for CD4+ cell count and plasma HIV-RNA level). CONCLUSIONS: These findings indicate that microangiopathy may be involved in the development of CMV disease in HIV-infectedpatients. Thus, detection of the presence of HIV-related retinal microangiopathy is important in the management of HIV-infectedpatients.
Authors: L M Mofenson; D R Harris; K Rich; W A Meyer; J S Read; J Moye; R P Nugent; J Korelitz; J Bethel; S Pahwa Journal: AIDS Date: 1999-01-14 Impact factor: 4.177
Authors: B Ledergerber; M Egger; V Erard; R Weber; B Hirschel; H Furrer; M Battegay; P Vernazza; E Bernasconi; M Opravil; D Kaufmann; P Sudre; P Francioli; A Telenti Journal: JAMA Date: 1999-12-15 Impact factor: 56.272
Authors: B D Kuppermann; J G Petty; D D Richman; W C Mathews; S C Fullerton; L S Rickman; W R Freeman Journal: Am J Ophthalmol Date: 1993-05-15 Impact factor: 5.258
Authors: William G Hodge; Jean-François Boivin; Stanley H Shapiro; Richard G Lalonde; Kirtida C Shah; Bradley D Murphy; Michel A Dionne; Aashish Goela Journal: Ophthalmology Date: 2004-07 Impact factor: 12.079